Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

NCT06963268 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria La Fe as lead sponsor.

NCT NCT06963268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06963268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Phase
Phase 3
Overall status
Recruiting
Start date
November 10, 2025
Completion date
June 30, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasms